8-K ·Filed Jul 15, 2026

PROF

Profound Medical Corp.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago SEC0001171843-26-004654
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This is a routine conference announcement with no material financial data. The investor session with sell-side analysts could generate modest attention, but no concrete catalysts are provided. Monitor for any data readouts from the CAPTAIN trial or other presentations that could move the stock.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
PROF ▼ -0.43% at T+20d
NEUTRAL call ✗ call lost -0.43% · α vs SPY -2.77% · entry $6.96 → $6.93
Next anchor: T+60d in 5d
Latest observation: T+54 -15.33% FF3 residual α
Entry anchored
Jul 14, 03:59 PM ET
via exchange tick
T+1d
-2.59%
call -2.59% · α -2.04%
$6.78
settled 3mo ago
T+5d
+0.43%
call +0.43% · α +1.41%
$6.99
settled 2mo ago
T+20d
-0.43%
call -0.43% · α -2.77%
$6.93
settled 7w ago
T+60d
—
call — · α —
—
in 5d

Price Chart

Loading chart...

Executive Summary

Profound Medical announced its TULSA Procedure will be featured in multiple presentations at the Society of Robotic Surgery Annual Meeting (SRS2026) in Fort Lauderdale, July 23-26, 2026. The company was also selected as one of eight companies for the Society of Incisionless Surgery plenary session, and management will participate in an investor session moderated by Stifel and Wells Fargo analysts. No financial data or guidance was provided.

Key Facts

  • TULSA Procedure highlighted in several presentations at SRS2026 (July 23-26, 2026)
  • CAPTAIN randomized controlled trial primary safety outcomes to be presented
  • Profound selected as one of only eight companies for SIS plenary session
  • Management to participate in investor session moderated by Stifel and Wells Fargo analysts on July 22, 2026

Financial Impact

No financial figures disclosed; routine conference presence announcement

Risk Factors

  • No new financial or operational guidance provided
  • Conference presentations may not lead to material commercial impact

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
80% bullish (5 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-004654
Exhibit: exh_991.htm0001171843-26-004654
Document: 0001171843-26-004654-index-headers.html0001171843-26-004654
Document: 0001171843-26-004654-index.html0001171843-26-004654
Document: 0001171843-26-004654.txt0001171843-26-004654
13 reports for PROF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PROF — sortable, filterable
TypeNow
Sep 4, 2026
28d ago
8-K
NEUTRAL ★ 2/10
$6.89 $5.81▼ −15.67%▼ −14.47%$5.85 (−15.09%)
Sep 3, 2026
29d ago
8-K
NEUTRAL ★ 3/10
$6.80 $5.97▼ −12.21%▼ −11.06%$5.85 (−13.97%)
Aug 17, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$6.55 $6.80▲ +3.82%▲ +5.01%$5.85 (−10.69%)
Aug 17, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$6.55 $6.80▲ +3.82%▲ +5.01%$5.85 (−10.69%)
Jul 24, 2026
10w ago
8-K
BULLISH ★ 6/10
$7.26 $7.25▼ −0.14%▼ −0.51%$5.85 (−19.42%)
Jul 15, 2026
11w ago
8-K
NEUTRAL ★ 2/10
$6.96 $6.99▲ +0.43%▲ +1.41%$5.85 (−15.95%)
May 14, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$6.97 $6.83▼ −2.01%▼ −2.97%$5.85 (−16.07%)
May 12, 2026
20w ago
S-3
NEUTRAL ★ 3/10
$7.10 $6.73▼ −5.21%▼ −4.05%$5.85 (−17.61%)
Apr 16, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$6.62 $6.75▲ +1.96%▲ +0.98%$5.85 (−11.63%)
Apr 14, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$6.26 $6.84▲ +9.27%▲ +7.87%$5.85 (−6.55%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (37h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access